TSH recombinante y determinación de tiroglobulina en el seguimiento del carcinoma diferenciado de tiroides

Parker, 1997, Cancer statistics, Cancer J Clin, 47, 5, 10.3322/canjclin.47.1.5 Hundhal, 1998, A national cancer data base report on 53.856 cases of thyroid carcinoma treated in US 1985-1995, Cancer, 83, 2638, 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 Tubiana, 1985, Long term results and prognosis factors in patients with differentiated thyroid carcinoma, Cancer, 55, 795, 10.1002/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z Mazzaferri, 1994, Long term impact of initial surgical and medical therapy on papillary and follicular cancer, Am J Med, 97, 418, 10.1016/0002-9343(94)90321-2 Schumberger, 1998, Papillary and follicular thyroid carcinomas, N Engl J Med, 338, 297, 10.1056/NEJM199801293380506 Schlumberger, 1999, Thyroid tumors, 167 Maxon, 1999, Detection of residual and recurrent thyroid cancer by radionuclide imaging, Thyroid, 9, 443, 10.1089/thy.1999.9.443 Schlumberger, 1998, Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma, Eur J Endocrinol, 138, 249, 10.1530/eje.0.1380249 Meier, 1994, Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study), J Clin Endocrinol Metab, 78, 188, 10.1210/jc.78.1.188 Ladenson, 1997, Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma, N Engl J Med, 337, 888, 10.1056/NEJM199709253371304 Haugen, 1999, A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remant or cancer, J Clin Endocrinol Metab, 84, 3877, 10.1210/jc.84.11.3877 Durski, 2000, McDougall. Recombinant human thyrotropin (rTSH) in the management of differentiated thyroid cancer, Nucl Med Commun, 21, 521, 10.1097/00006231-200006000-00004 Mariani, 2000, Clinical experience with recombinant human thyrotropin in the management of patients with differentiated thyroid cancer, Cancer Bioth Radiophar, 15, 211, 10.1089/cbr.2000.15.211 Robbins, 2001, Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma, J Clin Endocrinol Metab, 86, 619, 10.1210/jc.86.2.619 Cailleux, 2000, Is diagnostic iodide 131 scanning useful after total thyroid ablation for differentiated thyroid cancer?, J Clin Endocrinol Metab, 85, 175, 10.1210/jc.85.1.175 Pacini, 2002, Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment, J Clin Endocrinol Metab, 87, 1499, 10.1210/jc.87.4.1499 Pacini, 2001, Prediction of disease status by recombinant hu-man TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma, J Clin Endocrinol Metab, 86, 56876, 10.1210/jc.86.12.5686 Wartofsky, 2002, and the rTSH stimulated thyroglobulin study group. Management of low risk well differentieted thyroid cancer based only on thyroglobulin measurement after recombinat human thyrotropin, Thyroid, 12, 583, 10.1089/105072502320288438 Mazzaferri, 2002, Is diagnostic iodine 131 scaning with recombinat human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?, J Clin Endocrinol Metab, 87, 1490, 10.1210/jc.87.4.1490 Robbins, 2002, Is the serum thyroglobulin response to recombinant human thyrotropin sufficient by itself to monitor for residual thyroid carcinoma?, J Clin Endocrinol Metab, 87, 3242, 10.1210/jc.87.7.3242 Ladenson, 2001, Practical application of recombinant thyrotropin testing in clinical practice, Endocrine Prac, 7, 195, 10.4158/EP.7.3.195 Wartofsky, 2002, Using baseline and recombinant human TSH stimulated Tg measurements to manage thyroid cancer without diagnostic 131 I scaning, J Clin Endocrinol Metab, 87, 1486, 10.1210/jc.87.4.1486